Transdermal Drug Delivery as a Promising Approach for Treating Alzheimer Disease by Nishan Shah, Ph.D
Check out Nishan Shah, Ph.D’s publication in AAPS News Magazine! Read More…
Life Sciences
On-Demand Webinar on Novel ADC Conjugates
Summary: Antibody-drug conjugates (ADCs) are a novel class of drugs that combine the potency of small molecule drugs with the targeting capabilities of highly-specific antibodies. While there is a wide array of different biochemical methods used for making ADCs, each method can have a varying effect on the stability of these types of therapeutics. In
On-Demand Webinar on Novel ADC Conjugates Read More »
Delivering Science Better, through Versatility: Virtual Audits & Lab Tours!
Pace Life Sciences – April 2020 Pace Life Sciences – April 2020 Delivering Science Better, Through Versatility: Virtual Audits & Lab Tours! We have made the necessary adjustments to protect our employees and their families and to remain fully operational through the COVID-19 Pandemic. We understand that it is our duty to do everything we
Delivering Science Better, through Versatility: Virtual Audits & Lab Tours! Read More »
Pace Supports Leading Biotech and Pharmaceutical Companies in Active Pursuit of COVID-19 Vaccines and Therapies
Pace Life Sciences – March 2020 Pace Supports Leading Biotech and Pharmaceutical Companies in Active Pursuit of COVID-19 Vaccines and Therapies Pace Analytical® labs and facilities are fully operational, providing essential Public Health Services as noted by the CDC. Due to our advanced capabilities in the development and testing of gene therapies and other complex
Pace Life Sciences Supporting Essential Healthcare Services
Pace Life Sciences – March 2020 Pace Life Sciences Supporting Essential Healthcare Services Many Pace Life Sciences customers play a critical role in the healthcare industry to ensure patients receive the best treatments possible. As a provider of Essential Public Health Services, Pace is fully operational amid the COVID-19 pandemic, supporting our customers in their
Pace Life Sciences Supporting Essential Healthcare Services Read More »
What is Gene Therapy?
One of the more exciting areas of growth within our Life Sciences Division over the year has been the establishment of services designed to support the development of gene therapy. Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. A gene that is
What is Gene Therapy? Read More »
Tips For Hiring The Best Scientific Staff
The hiring process for scientific candidates can be a long and tedious process of reviewing resumes, interviews, offers, and onboarding. Although interviewing takes a lot of time from the employer and the candidate, it is the most important step in the hiring process. Hiring the best talent for your team requires interviews that properly assess
Tips For Hiring The Best Scientific Staff Read More »
Pace’s Wolfe Laboratories Celebrates 20 Year Anniversary
Two decades of pharmaceutical development and customer service leads to exciting milestone Woburn, MA: Wolfe Laboratories, a subsidiary of Pace Analytical Life Sciences, has reached a special milestone as it celebrates 20 years as a premier contract research organization that provides integrated drug development solutions to the biopharmaceutical industry. Founded in 1999 by Senior Vice
Pace’s Wolfe Laboratories Celebrates 20 Year Anniversary Read More »
Pace Life Sciences Ready for March 1st Changes to Residual Solvents
At Pace Analytical we understand the importance of keeping up with changes in the marketplace. On March 1, 2019, a revision of USP <467>, Residual Solvents, will become effective. This revision clarifies verification and validation requirements for use of the monograph for Class 1, 2, and 3 residual solvent determination in compendial and non-compendial materials.
Pace Life Sciences Ready for March 1st Changes to Residual Solvents Read More »
PFAS CHANGES DETAILED BY EPA
February 14, 2019 – Andrew Wheeler, the acting administrator of the Environmental Protection Agency (EPA), announced a set of comprehensive actions to address the presence of Per- and Polyfluoroalkyl Substances (PFAS) in the environment. The actions will provide a framework for the future monitoring, detection, and clean-up of PFAS and leverage multiple programs and disciplines.
PFAS CHANGES DETAILED BY EPA Read More »